Related Experiment Video
Updated: Feb 15, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors
Erik C Dreaden1,2,3, Yi Wen Kong1,4, Mohiuddin A Quadir1,2,5
1Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology Cambridge MA 02139.
Abstract:
DNA damaging chemotherapy is a cornerstone of current front-line treatments for advanced ovarian cancer (OC). Despite the fact that a majority of these patients initially respond to therapy, most will relapse with chemo-resistant disease; therefore, adjuvant treatments that synergize with DNA-damaging chemotherapy could improve treatment outcomes and survival in patients with this deadly disease. Here, we report the development of a nanoscale peptide-nucleic acid complex that facilitates tumor-specific RNA interference therapy to chemosensitize advanced ovarian tumors to frontline platinum/taxane therapy. We found that the nanoplex-mediated silencing of the protein kinase, MK2, profoundly sensitized mouse models of high-grade serous OC to cytotoxic chemotherapy by blocking p38/MK2-dependent cell cycle checkpoint maintenance. Combined RNAi therapy improved overall survival by 37% compared with platinum/taxane chemotherapy alone and decreased metastatic spread to the lungs without observable toxic side effects. These findings suggest (a) that peptide nanoplexes can serve as safe and effective delivery vectors for siRNA and (b) that combined inhibition of MK2 could improve treatment outcomes in patients currently receiving frontline chemotherapy for advanced OC.
Insights
This study developed a nanoscale therapy to resensitize ovarian cancer to chemotherapy. Combining RNA interference targeting MK2 with chemotherapy significantly improved survival and reduced metastasis in mouse models.
Area of Science:
- Oncology
- Nanotechnology
- Molecular Biology
Background:
- DNA damaging chemotherapy is standard for advanced ovarian cancer (OC).
- Most patients initially respond but develop chemo-resistance, necessitating novel adjuvant therapies.
- Improved treatment strategies are crucial for enhancing survival in advanced OC.
Purpose of the Study:
- To develop a nanoscale therapy to chemosensitize advanced ovarian tumors to platinum/taxane chemotherapy.
- To investigate the efficacy of RNA interference targeting MK2 (a protein kinase) in overcoming chemo-resistance.
- To evaluate the safety and effectiveness of peptide nanoplexes as delivery vectors for siRNA.
Main Methods:
- Development of a nanoscale peptide-nucleic acid complex for tumor-specific RNA interference (RNAi).
- Silencing of the protein kinase MK2 using nanoplex-mediated RNAi in mouse models of high-grade serous OC.
- Assessment of chemosensitization to platinum/taxane therapy and impact on cell cycle checkpoints.
Main Results:
- Nanoplex-mediated MK2 silencing profoundly sensitized OC models to chemotherapy by blocking p38/MK2-dependent cell cycle checkpoints.
- Combined RNAi therapy improved overall survival by 37% compared to chemotherapy alone.
- A significant decrease in lung metastasis was observed without apparent toxic side effects.
Conclusions:
- Peptide nanoplexes are safe and effective delivery vectors for small interfering RNA (siRNA).
- Combined inhibition of MK2 can enhance treatment outcomes for advanced ovarian cancer patients undergoing frontline chemotherapy.
- This approach offers a promising strategy to overcome chemo-resistance in ovarian cancer.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Peptide Bonds
Graded Potential
Graded potentials fall into two categories: depolarizing and hyperpolarizing. Depolarizing graded potentials typically occur when sodium (Na+) or...
RNA Stability

